These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31004607)

  • 1. Can cardiac resynchronization therapy be used as a tool to reduce sudden cardiac arrest risk?
    Galand V; Singh JP; Heist EK
    Prog Cardiovasc Dis; 2019; 62(3):242-248. PubMed ID: 31004607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection?
    Galand V; Martins RP; Behar N; Pichard C; Mabo P; Leclercq C
    Curr Heart Fail Rep; 2020 Aug; 17(4):116-124. PubMed ID: 32506301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy.
    Linhart M; Doltra A; Acosta J; Borràs R; Jáuregui B; Fernández-Armenta J; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Soto-Iglesias D; Villuendas R; Perea RJ; Ortiz JT; Bosch X; Auricchio A; Mont L; Berruezo A
    Europace; 2020 Sep; 22(9):1391-1400. PubMed ID: 32898254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review.
    Barra S; Providência R; Narayanan K; Boveda S; Duehmke R; Garcia R; Leyva F; Roger V; Jouven X; Agarwal S; Levy WC; Marijon E
    Eur Heart J; 2020 Jun; 41(21):1976-1986. PubMed ID: 31750896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy and automatic implantable cardiac defibrillators in the treatment of heart failure: a review article.
    Vesty J; Rasmusson KD; Hall J; Schmitz S; Brush S
    J Am Acad Nurse Pract; 2004 Oct; 16(10):441-50. PubMed ID: 15543921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The assessment of factors influencing occurrence of adequate interventions of cardiac resynchronization therapy with cardioverter-defibrillator implanted in primary prevention of sudden cardiac death in dilative cardiomyopathy and percentage of biventricular pacing].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J; Matusik P
    Przegl Lek; 2017; 74(4):157-62. PubMed ID: 29696953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure as a substrate and trigger for ventricular tachycardia.
    Alvarez CK; Cronin E; Baker WL; Kluger J
    J Interv Card Electrophysiol; 2019 Dec; 56(3):229-247. PubMed ID: 31598875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death prophylaxis in heart failure.
    Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
    Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.
    Biton Y; Baman JR; Polonsky B
    Heart Fail Rev; 2016 Jul; 21(4):433-46. PubMed ID: 26910804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
    Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
    Zeitler EP; Friedman DJ; Daubert JP; Al-Khatib SM; Solomon SD; Biton Y; McNitt S; Zareba W; Moss AJ; Kutyifa V
    J Am Coll Cardiol; 2017 May; 69(19):2369-2379. PubMed ID: 28494974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    Biton Y; Goldenberg I; Kutyifa V; Baman JR; Solomon S; Moss AJ; Szepietowska B; McNitt S; Polonsky B; Zareba W; Barsheshet A
    J Am Coll Cardiol; 2016 Jan; 67(3):303-12. PubMed ID: 26796396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.